Skip to main content
Erschienen in: Endocrine 2/2020

30.10.2019 | Original Article

Development and assessment of machine learning algorithms for predicting remission after transsphenoidal surgery among patients with acromegaly

Erschienen in: Endocrine | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Preoperative prediction of transsphenoidal surgical (TSS) response is important for determining individual treatment strategies for acromegaly. There is currently no accurate predictive model for TSS response for acromegaly. The current study sought to develop and validate machine learning (ML)-based models for preoperative prediction of TSS response for acromegaly.

Methods

Six hundred sixty-eight patients with acromegaly were enrolled and divided into training (n = 534) and text datasets (n = 134) in this retrospective, data mining and ML study. The forward search algorithm was used to select features, and six ML algorithms were applied to construct TSS response prediction models. The performance of these ML models was validated using receiver operating characteristics analysis. Model calibration, discrimination ability, and clinical usefulness were also assessed.

Results

Three hundred forty-nine (52.2%) patients achieved postoperative remission criteria and exhibited good TSS response. A univariate analysis was conducted and eight features, including age, hypertension, ophthalmic disorders, GH, IGF-1, nadir GH, maximal tumor diameter, and Knosp grade, were significantly associated with the TSS response in patients with acromegaly. After feature selection, the gradient boosting decision tree (GBDT), which was constructed with the eight significant features showed the best favorable discriminatory ability both the training (AUC = 0.8555) and validation (AUC = 0.8178) cohorts. The GBDT model showed good discrimination ability and calibration, with the highest levels of accuracy and specificity, and provided better estimates of TTS responses of patients with acromegaly compared with using only the Knosp grade. Decision curve analysis confirmed that the model was clinically useful.

Conclusions

ML-based models could aid neurosurgeons in the preoperative prediction of TTS response for patients with acromegaly, and could contribute to determining individual treatment strategies.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat S. Melmed, M.D. Bronstein, P. Chanson, A. Klibanski, F.F. Casanueva, J.A.H. Wass et al. A Consensus Statement on acromegaly therapeutic outcomes. Nat. Rev. Endocrinol. 14(9), 552–61 (2018)PubMed S. Melmed, M.D. Bronstein, P. Chanson, A. Klibanski, F.F. Casanueva, J.A.H. Wass et al. A Consensus Statement on acromegaly therapeutic outcomes. Nat. Rev. Endocrinol. 14(9), 552–61 (2018)PubMed
2.
Zurück zum Zitat D. Esposito, O. Ragnarsson, D. Granfeldt, T. Marlow, G. Johannsson, D.S. Olsson, Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study. Eur. J. Endocrinol. 178(5), 459–69. (2018)PubMed D. Esposito, O. Ragnarsson, D. Granfeldt, T. Marlow, G. Johannsson, D.S. Olsson, Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study. Eur. J. Endocrinol. 178(5), 459–69. (2018)PubMed
3.
Zurück zum Zitat C. Leopoldo, F. Leopoldo, A. Santos, J.C.E. Veiga, J.V.J. Lima, N.M. Scalissi et al. Long term follow-up of growth hormone-secreting pituitary adenomas submitted to endoscopic endonasal surgery. Arq. Neuropsiquiatr. 75(5), 301–6 (2017)PubMed C. Leopoldo, F. Leopoldo, A. Santos, J.C.E. Veiga, J.V.J. Lima, N.M. Scalissi et al. Long term follow-up of growth hormone-secreting pituitary adenomas submitted to endoscopic endonasal surgery. Arq. Neuropsiquiatr. 75(5), 301–6 (2017)PubMed
4.
Zurück zum Zitat A. Buliman, L.G. Tataranu, V. Ciubotaru, T.L. Cazac, C. Dumitrache, The multimodal management of GH-secreting pituitary adenomas: predictive factors, strategies and outcomes. J. Med. Life 9(2), 187–92 (2016)PubMedPubMedCentral A. Buliman, L.G. Tataranu, V. Ciubotaru, T.L. Cazac, C. Dumitrache, The multimodal management of GH-secreting pituitary adenomas: predictive factors, strategies and outcomes. J. Med. Life 9(2), 187–92 (2016)PubMedPubMedCentral
5.
Zurück zum Zitat S. Melmed, A. Colao, A. Barkan, M. Molitch, A.B. Grossman, D. Kleinberg et al. Guidelines for acromegaly management: an update. J. Clin. Endocrinol. Metab. 94(5), 1509–17 (2009)PubMed S. Melmed, A. Colao, A. Barkan, M. Molitch, A.B. Grossman, D. Kleinberg et al. Guidelines for acromegaly management: an update. J. Clin. Endocrinol. Metab. 94(5), 1509–17 (2009)PubMed
6.
Zurück zum Zitat L. Katznelson, E.R. Laws Jr., S. Melmed, M.E. Molitch, M.H. Murad, A. Utz et al. Acromegaly: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(11), 3933–51 (2014)PubMed L. Katznelson, E.R. Laws Jr., S. Melmed, M.E. Molitch, M.H. Murad, A. Utz et al. Acromegaly: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(11), 3933–51 (2014)PubMed
7.
Zurück zum Zitat B. Zhao, Y.K. Wei, G.L. Li, Y.N. Li, Y. Yao, J. Kang et al. Extended transsphenoidal approach for pituitary adenomas invading the anterior cranial base, cavernous sinus, and clivus: a single-center experience with 126 consecutive cases. J. Neurosurg. 112(1), 108–17 (2010)PubMed B. Zhao, Y.K. Wei, G.L. Li, Y.N. Li, Y. Yao, J. Kang et al. Extended transsphenoidal approach for pituitary adenomas invading the anterior cranial base, cavernous sinus, and clivus: a single-center experience with 126 consecutive cases. J. Neurosurg. 112(1), 108–17 (2010)PubMed
8.
Zurück zum Zitat M.E. Sughrue, E.F. Chang, R.A. Gabriel, M.K. Aghi, L.S. Blevins, Excess mortality for patients with residual disease following resection of pituitary adenomas. Pituitary 14(3), 276–83 (2011)PubMed M.E. Sughrue, E.F. Chang, R.A. Gabriel, M.K. Aghi, L.S. Blevins, Excess mortality for patients with residual disease following resection of pituitary adenomas. Pituitary 14(3), 276–83 (2011)PubMed
9.
Zurück zum Zitat S.M. Carlsen, M. Lund-Johansen, T. Schreiner, S. Aanderud, O. Johannesen, J. Svartberg et al. Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial. J. Clin. Endocrinol. Metab. 93(8), 2984–90 (2008)PubMed S.M. Carlsen, M. Lund-Johansen, T. Schreiner, S. Aanderud, O. Johannesen, J. Svartberg et al. Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial. J. Clin. Endocrinol. Metab. 93(8), 2984–90 (2008)PubMed
10.
Zurück zum Zitat V.S. Nunes, J.M. Correa, M.E. Puga, E.M. Silva, C.L. Boguszewski, Preoperative somatostatin analogues versus direct transsphenoidal surgery for newly-diagnosed acromegaly patients: a systematic review and meta-analysis using the GRADE system. Pituitary 18(4), 500–8 (2015)PubMed V.S. Nunes, J.M. Correa, M.E. Puga, E.M. Silva, C.L. Boguszewski, Preoperative somatostatin analogues versus direct transsphenoidal surgery for newly-diagnosed acromegaly patients: a systematic review and meta-analysis using the GRADE system. Pituitary 18(4), 500–8 (2015)PubMed
11.
Zurück zum Zitat S. Bacigaluppi, F. Gatto, P. Anania, N.L. Bragazzi, D.C. Rossi, G. Benvegnu et al. Impact of pre-treatment with somatostatin analogs on surgical management of acromegalic patients referred to a single center. Endocrine 51(3), 524–33. (2016)PubMed S. Bacigaluppi, F. Gatto, P. Anania, N.L. Bragazzi, D.C. Rossi, G. Benvegnu et al. Impact of pre-treatment with somatostatin analogs on surgical management of acromegalic patients referred to a single center. Endocrine 51(3), 524–33. (2016)PubMed
12.
Zurück zum Zitat S. Yano, N. Shinojima, J. Kawashima, T. Kondo, T. Hide, Intraoperative scoring system to predict postoperative remission in endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas. World Neurosurg. 105, 375–85. (2017)PubMed S. Yano, N. Shinojima, J. Kawashima, T. Kondo, T. Hide, Intraoperative scoring system to predict postoperative remission in endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas. World Neurosurg. 105, 375–85. (2017)PubMed
13.
Zurück zum Zitat W.J. Zhou, S.C. Ma, M. Zhao, C. Liu, X.D. Guan, Z.S. Bao et al. Risk factors and the prognosis of sexual dysfunction in male patients with pituitary adenomas: a multivariate analysis. Asian J. Androl. 20(1), 43–9 (2018)PubMed W.J. Zhou, S.C. Ma, M. Zhao, C. Liu, X.D. Guan, Z.S. Bao et al. Risk factors and the prognosis of sexual dysfunction in male patients with pituitary adenomas: a multivariate analysis. Asian J. Androl. 20(1), 43–9 (2018)PubMed
14.
Zurück zum Zitat M. Birkhahn, A.P. Mitra, R.J. Cote, Molecular markers for bladder cancer: the road to a multimarker approach. Expert Rev. Anticancer Ther. 7(12), 1717–27. (2007)PubMed M. Birkhahn, A.P. Mitra, R.J. Cote, Molecular markers for bladder cancer: the road to a multimarker approach. Expert Rev. Anticancer Ther. 7(12), 1717–27. (2007)PubMed
15.
Zurück zum Zitat Y. Huang, Z. Liu, L. He, X. Chen, D. Pan, Z. Ma et al. Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer. Radiology 281(3), 947–57. (2016)PubMed Y. Huang, Z. Liu, L. He, X. Chen, D. Pan, Z. Ma et al. Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer. Radiology 281(3), 947–57. (2016)PubMed
16.
Zurück zum Zitat T.J. Cleophas, Machine learning in therapeutic research: the hard work of outlier detection in large data. Am. J. Ther. 23(3), e837–43 (2016)PubMed T.J. Cleophas, Machine learning in therapeutic research: the hard work of outlier detection in large data. Am. J. Ther. 23(3), e837–43 (2016)PubMed
17.
Zurück zum Zitat M.H. Al-Mallah, R. Elshawi, A.M. Ahmed, W.T. Qureshi, C.A. Brawner, M.J. Blaha et al. Using Machine Learning to Define the Association between Cardiorespiratory Fitness and All-Cause Mortality (from the Henry Ford Exercise Testing Project). Am. J. Cardiol. 120(11), 2078–84. (2017)PubMed M.H. Al-Mallah, R. Elshawi, A.M. Ahmed, W.T. Qureshi, C.A. Brawner, M.J. Blaha et al. Using Machine Learning to Define the Association between Cardiorespiratory Fitness and All-Cause Mortality (from the Henry Ford Exercise Testing Project). Am. J. Cardiol. 120(11), 2078–84. (2017)PubMed
18.
Zurück zum Zitat A. Rajkomar, J. Dean, I. Kohane, Machine Learning in Medicine. N. Engl. J. Med 380(14), 1347–58. (2019)PubMed A. Rajkomar, J. Dean, I. Kohane, Machine Learning in Medicine. N. Engl. J. Med 380(14), 1347–58. (2019)PubMed
20.
Zurück zum Zitat A.M. Bur, A. Holcomb, S. Goodwin, J. Woodroof, O. Karadaghy, Y. Shnayder et al. Machine learning to predict occult nodal metastasis in early oral squamous cell carcinoma. Oral. Oncol. 92, 20–5 (2019)PubMed A.M. Bur, A. Holcomb, S. Goodwin, J. Woodroof, O. Karadaghy, Y. Shnayder et al. Machine learning to predict occult nodal metastasis in early oral squamous cell carcinoma. Oral. Oncol. 92, 20–5 (2019)PubMed
21.
Zurück zum Zitat C. Rubbert, C. Mathys, C. Jockwitz, C.J. Hartmann, S.B. Eickhoff, F. Hoffstaedter et al. Machine-learning identifies parkinson’s disease patients based on resting-state between-network functional connectivity. Br. J. Radio. 92, 20180886 (2019) C. Rubbert, C. Mathys, C. Jockwitz, C.J. Hartmann, S.B. Eickhoff, F. Hoffstaedter et al. Machine-learning identifies parkinson’s disease patients based on resting-state between-network functional connectivity. Br. J. Radio. 92, 20180886 (2019)
22.
Zurück zum Zitat H. Yu, H. Wu, W. Wang, S. Jolly, J.Y. Jin, C. Hu, et al., Machine learning to build and validate a model for radiation pneumonitis prediction in patients with non-small-cell lung cancer. Clin. Cancer Res 25, 4343–4350 (2019).PubMed H. Yu, H. Wu, W. Wang, S. Jolly, J.Y. Jin, C. Hu, et al., Machine learning to build and validate a model for radiation pneumonitis prediction in patients with non-small-cell lung cancer. Clin. Cancer Res 25, 4343–4350 (2019).PubMed
23.
Zurück zum Zitat X. Guo, L. Gao, Y. Zhao, M. Wang, B. Jiang, Q. Wang et al. Characteristics of the upper respiratory tract in patients with acromegaly and correlations with obstructive sleep apnoea/hypopnea syndrome. Sleep. Med. 48, 27–34 (2018)PubMed X. Guo, L. Gao, Y. Zhao, M. Wang, B. Jiang, Q. Wang et al. Characteristics of the upper respiratory tract in patients with acromegaly and correlations with obstructive sleep apnoea/hypopnea syndrome. Sleep. Med. 48, 27–34 (2018)PubMed
24.
Zurück zum Zitat E. Knosp, E. Steiner, K. Kitz, C. Matula, Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33(4), 610–7 (1993). discussion 7–8PubMed E. Knosp, E. Steiner, K. Kitz, C. Matula, Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33(4), 610–7 (1993). discussion 7–8PubMed
25.
Zurück zum Zitat A. Di Ieva, F. Rotondo, L.V. Syro, M.D. Cusimano, K. Kovacs, Aggressive pituitary adenomas–diagnosis and emerging treatments. Nat. Rev. Endocrinol. 10(7), 423–35 (2014)PubMed A. Di Ieva, F. Rotondo, L.V. Syro, M.D. Cusimano, K. Kovacs, Aggressive pituitary adenomas–diagnosis and emerging treatments. Nat. Rev. Endocrinol. 10(7), 423–35 (2014)PubMed
26.
Zurück zum Zitat G.E.A.P.A. Batista, M.C. Monard, An analysis of four missing data treatment methods for supervised learning. Appl. Artif. Intell. 17(5–6), 519–33 (2003) G.E.A.P.A. Batista, M.C. Monard, An analysis of four missing data treatment methods for supervised learning. Appl. Artif. Intell. 17(5–6), 519–33 (2003)
27.
Zurück zum Zitat L.A. Shalabi, Z. Shaaban, B. Kasasbeh, Data mining: a preprocessing engine. J. Computer Sci. 2(9), 735–9 (2006) L.A. Shalabi, Z. Shaaban, B. Kasasbeh, Data mining: a preprocessing engine. J. Computer Sci. 2(9), 735–9 (2006)
28.
Zurück zum Zitat Y. Liu, X. Liu, X. Hong, P. Liu, X. Bao, Y. Yao et al. Prediction of recurrence after transsphenoidal surgery for cushing’s disease: the use of machine learning algorithms. Neuroendocrinology 108(3), 201–10. (2019)PubMed Y. Liu, X. Liu, X. Hong, P. Liu, X. Bao, Y. Yao et al. Prediction of recurrence after transsphenoidal surgery for cushing’s disease: the use of machine learning algorithms. Neuroendocrinology 108(3), 201–10. (2019)PubMed
29.
Zurück zum Zitat Y.V. Sun, Multigenic modeling of complex disease by random forests. Adv. Genet 72, 73–99 (2010)PubMed Y.V. Sun, Multigenic modeling of complex disease by random forests. Adv. Genet 72, 73–99 (2010)PubMed
30.
Zurück zum Zitat B. Fu, P. Liu, J. Lin, L. Deng, K. Hu, H. Zheng. Predicting invasive disease-free survival for early-stage breast cancer patients using follow-up clinical data. IEEE Trans. Biomed. Eng. 66(7), 2053–64 (2019) B. Fu, P. Liu, J. Lin, L. Deng, K. Hu, H. Zheng. Predicting invasive disease-free survival for early-stage breast cancer patients using follow-up clinical data. IEEE Trans. Biomed. Eng. 66(7), 2053–64 (2019)
31.
Zurück zum Zitat Y. Jung, Multiple predicting K-fold cross-validation for model selection. J. Nonparametr. Stat. 30(1), 197–215 (2018) Y. Jung, Multiple predicting K-fold cross-validation for model selection. J. Nonparametr. Stat. 30(1), 197–215 (2018)
32.
Zurück zum Zitat S.M. Erturk, Receiver operating characteristic analysis. AJR Am. J. Roentgenol. 197(4), W784 (2011).PubMed S.M. Erturk, Receiver operating characteristic analysis. AJR Am. J. Roentgenol. 197(4), W784 (2011).PubMed
33.
Zurück zum Zitat A.A. Kramer, J.E. Zimmerman, Assessing the calibration of mortality benchmarks in critical care: The Hosmer-Lemeshow test revisited. Crit. Care Med 35(9), 2052–6 (2007)PubMed A.A. Kramer, J.E. Zimmerman, Assessing the calibration of mortality benchmarks in critical care: The Hosmer-Lemeshow test revisited. Crit. Care Med 35(9), 2052–6 (2007)PubMed
34.
Zurück zum Zitat A.J. Vickers, A.M. Cronin, E.B. Elkin, M. Gonen, Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inf. Decis. Mak. 8, 53 (2008) A.J. Vickers, A.M. Cronin, E.B. Elkin, M. Gonen, Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inf. Decis. Mak. 8, 53 (2008)
35.
Zurück zum Zitat E.H. Kim, M.C. Oh, J.H. Chang, J.H. Moon, C.R. Ku, W.S. Chang et al. Postoperative gamma knife radiosurgery for cavernous sinus-invading growth hormone-secreting pituitary adenomas. World Neurosurg. 110, e534–e45. (2018)PubMed E.H. Kim, M.C. Oh, J.H. Chang, J.H. Moon, C.R. Ku, W.S. Chang et al. Postoperative gamma knife radiosurgery for cavernous sinus-invading growth hormone-secreting pituitary adenomas. World Neurosurg. 110, e534–e45. (2018)PubMed
36.
Zurück zum Zitat J.J. Jacob, J.S. Bevan, Should all patients with acromegaly receive somatostatin analogue therapy before surgery and, if so, for how long? Clin. Endocrinol. 81(6), 812–7 (2014) J.J. Jacob, J.S. Bevan, Should all patients with acromegaly receive somatostatin analogue therapy before surgery and, if so, for how long? Clin. Endocrinol. 81(6), 812–7 (2014)
37.
Zurück zum Zitat L. Duan, H. Zhu, B. Xing, F. Gu, Prolonged preoperative treatment of acromegaly with somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1-3): a retrospective cohort study conducted at a single center. BMC Endocr. Disord. 17(1), 55 (2017)PubMedPubMedCentral L. Duan, H. Zhu, B. Xing, F. Gu, Prolonged preoperative treatment of acromegaly with somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1-3): a retrospective cohort study conducted at a single center. BMC Endocr. Disord. 17(1), 55 (2017)PubMedPubMedCentral
38.
Zurück zum Zitat C.B. Newman, S. Melmed, A. George, D. Torigian, M. Duhaney, P. Snyder et al. Octreotide as primary therapy for acromegaly. J. Clin. Endocrinol. Metab. 83(9), 3034–40. (1998)PubMed C.B. Newman, S. Melmed, A. George, D. Torigian, M. Duhaney, P. Snyder et al. Octreotide as primary therapy for acromegaly. J. Clin. Endocrinol. Metab. 83(9), 3034–40. (1998)PubMed
39.
Zurück zum Zitat M. Fleseriu, A.R. Hoffman, L. Katznelson, A. Neuroendocrine; Pituitary Scientific C, American association of clinical endocrinologists and american college of endocrinology disease state clinical review: management of acromegaly patients: what is the role of pre-operative medical therapy? Endocr. Pract. 21(6), 668–73 (2015)PubMed M. Fleseriu, A.R. Hoffman, L. Katznelson, A. Neuroendocrine; Pituitary Scientific C, American association of clinical endocrinologists and american college of endocrinology disease state clinical review: management of acromegaly patients: what is the role of pre-operative medical therapy? Endocr. Pract. 21(6), 668–73 (2015)PubMed
40.
Zurück zum Zitat N. Qiao. A systematic review on machine learning in sellar region diseases: quality and reporting items. Endocr. Connect. 8(7), 952–60 (2019)PubMedPubMedCentral N. Qiao. A systematic review on machine learning in sellar region diseases: quality and reporting items. Endocr. Connect. 8(7), 952–60 (2019)PubMedPubMedCentral
41.
Zurück zum Zitat V.E. Staartjes, C.M. Zattra, K. Akeret, N. Maldaner, G. Muscas, C.H. Bas van Niftrik et al. Neural network-based identification of patients at high risk for intraoperative cerebrospinal fluid leaks in endoscopic pituitary surgery. J. Neurosurg. 21, 1–7 (2019) V.E. Staartjes, C.M. Zattra, K. Akeret, N. Maldaner, G. Muscas, C.H. Bas van Niftrik et al. Neural network-based identification of patients at high risk for intraoperative cerebrospinal fluid leaks in endoscopic pituitary surgery. J. Neurosurg. 21, 1–7 (2019)
42.
Zurück zum Zitat V.E. Staartjes, C. Serra, G. Muscas, N. Maldaner, K. Akeret, C.H.B. van Niftrik et al. Utility of deep neural networks in predicting gross-total resection after transsphenoidal surgery for pituitary adenoma: a pilot study. Neurosurg. Focus 45(5), E12 (2018)PubMed V.E. Staartjes, C. Serra, G. Muscas, N. Maldaner, K. Akeret, C.H.B. van Niftrik et al. Utility of deep neural networks in predicting gross-total resection after transsphenoidal surgery for pituitary adenoma: a pilot study. Neurosurg. Focus 45(5), E12 (2018)PubMed
43.
Zurück zum Zitat T.C. Hollon, A. Parikh, B. Pandian, J. Tarpeh, D.A. Orringer, A.L. Barkan et al. A machine learning approach to predict early outcomes after pituitary adenoma surgery. Neurosurg. Focus 45(5), E8 (2018)PubMed T.C. Hollon, A. Parikh, B. Pandian, J. Tarpeh, D.A. Orringer, A.L. Barkan et al. A machine learning approach to predict early outcomes after pituitary adenoma surgery. Neurosurg. Focus 45(5), E8 (2018)PubMed
44.
Zurück zum Zitat H. Babu, A. Ortega, M. Nuno, A. Dehghan, A. Schweitzer, H.V. Bonert et al. Long-term endocrine outcomes following endoscopic endonasal transsphenoidal surgery for acromegaly and associated prognostic factors. Neurosurgery 81(2), 357–66. (2017)PubMed H. Babu, A. Ortega, M. Nuno, A. Dehghan, A. Schweitzer, H.V. Bonert et al. Long-term endocrine outcomes following endoscopic endonasal transsphenoidal surgery for acromegaly and associated prognostic factors. Neurosurgery 81(2), 357–66. (2017)PubMed
45.
Zurück zum Zitat M.T. Ribeiro, S. Singh, C. Guestrin. “Why Should I Trust You?”: Explaining the Predictions of Any Classifier. (2016) M.T. Ribeiro, S. Singh, C. Guestrin. “Why Should I Trust You?”: Explaining the Predictions of Any Classifier. (2016)
46.
Zurück zum Zitat Rudin C. Please Stop Explaining Black Box Models for High Stakes Decisions. (2018) Rudin C. Please Stop Explaining Black Box Models for High Stakes Decisions. (2018)
47.
Zurück zum Zitat I. Shimon, Z.R. Cohen, Z. Ram, M. Hadani, Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 48(6), 1239–43 (2001)PubMed I. Shimon, Z.R. Cohen, Z. Ram, M. Hadani, Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 48(6), 1239–43 (2001)PubMed
48.
Zurück zum Zitat I. Anik, B. Cabuk, A. Gokbel, A. Selek, B. Cetinarslan, Y. Anik et al. Endoscopic transsphenoidal approach for acromegaly with remission rates in 401 patients: 2010 consensus criteria. World Neurosurg. 108, 278–90. (2017)PubMed I. Anik, B. Cabuk, A. Gokbel, A. Selek, B. Cetinarslan, Y. Anik et al. Endoscopic transsphenoidal approach for acromegaly with remission rates in 401 patients: 2010 consensus criteria. World Neurosurg. 108, 278–90. (2017)PubMed
49.
Zurück zum Zitat X. Antunes, N. Ventura, G.B. Camilo, L.E. Wildemberg, A. Guasti, P.J.M. Pereira et al. Predictors of surgical outcome and early criteria of remission in acromegaly. Endocrine 60(3), 415–22. (2018)PubMed X. Antunes, N. Ventura, G.B. Camilo, L.E. Wildemberg, A. Guasti, P.J.M. Pereira et al. Predictors of surgical outcome and early criteria of remission in acromegaly. Endocrine 60(3), 415–22. (2018)PubMed
Metadaten
Titel
Development and assessment of machine learning algorithms for predicting remission after transsphenoidal surgery among patients with acromegaly
Publikationsdatum
30.10.2019
Erschienen in
Endocrine / Ausgabe 2/2020
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-02121-6

Weitere Artikel der Ausgabe 2/2020

Endocrine 2/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.